Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast-cancer”

16,844 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 16,844 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02482376
What this trial is testing

Preoperative Single-Fraction Radiotherapy in Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Duke University 110
Not applicableStudy completedNCT02800317
What this trial is testing

RISAS Procedure in Node Positive Breast Cancer Following NAC

Who this might be right for
Breast NeoplasmNeoadjuvant TherapyAxillary Lymph Nodes+1 more
Erasmus Medical Center 248
Not applicableNot Yet RecruitingNCT06881940
What this trial is testing

Cardiac Rehabilitation Program on the Prevention of Cardiotoxicity in Breast Cancer Patients Undergoing Treatment With Anthracyclines and/or Trastuzumab

Who this might be right for
Cancer Therapy-Related Cardiac Dysfunction
Instituto Nacional de Cardiologia Ignacio Chavez 284
Not applicableStudy completedNCT03707574
What this trial is testing

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study

Who this might be right for
Advanced Malignant NeoplasmAdvanced MelanomaAdvanced Renal Cell Carcinoma+51 more
National Cancer Institute (NCI) 64
Testing effectiveness (Phase 2)Study completedNCT02544997
What this trial is testing

A Phase II, Single-Arm Trial of Poziotinib as Salvage Treatment in Patients With Metastatic Breast Cancer Who Has HER2 or EGFR Mutation or Activated AR or EGFR Pathway

Who this might be right for
Metastatic Breast Cancer
Samsung Medical Center 5
Testing effectiveness (Phase 2)WithdrawnNCT00080613
What this trial is testing

Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer

Who this might be right for
Stage II Breast CancerStage IIIA Breast CancerStage IIIB Breast Cancer+1 more
Robert H. Lurie Cancer Center
Post-approval studies (Phase 4)Not Yet RecruitingNCT06245824
What this trial is testing

Trastuzumab Deruxtecan (T-DXd) With Pyrotinib in First-line HER2-positive Unresectable or Metastatic Breast Cancer Trial

Who this might be right for
Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 51
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06680596
What this trial is testing

Detecting Tumor DNA in the Blood of HR+/HER2-low Metastatic Breast Cancer Patients to Find Candidates for T-DXd Therapy

Who this might be right for
Breast Cancer MetastaticBreast Cancer Stage IV
UNICANCER 80
Testing effectiveness (Phase 2)Study completedNCT04296162
What this trial is testing

Oral Vinorelbine or Capecitabine Combined With Trastuzumab as Adjuvant Treatment for Patients With Lymph Node Negative, HER-2 Positive and Small Tumor Size Breast Cancer (ORCHID)

Who this might be right for
Breast Cancer
Fudan University 182
Not applicableStudy completedNCT00580086
What this trial is testing

Monitoring Response to Neoadjuvant Chemotherapy by the Use of Breast Proton MR Spectroscopy

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 19
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05519670
What this trial is testing

A Phase 1b/2 Trial Evaluating Safety and Efficacy of CAPecitabine in Combination With Ni-rapaRIb in HER2-negative Advanced Breast canCEr

Who this might be right for
Breast Cancer
Institut Paoli-Calmettes 72
Testing effectiveness (Phase 2)UnknownNCT02596373
What this trial is testing

Mitoxantrone Hydrochloride Liposome Injection in Advanced Recurrent or Metastatic Breast Cancer

Who this might be right for
Advanced Recurrent or Metastatic Breast Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 60
Testing effectiveness (Phase 2)UnknownNCT00353717
What this trial is testing

Combined Treatment of Cetuximab and Paclitaxel in Basal Like Breast Carcinoma

Who this might be right for
Breast Neoplasms
Hadassah Medical Organization 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT01937117
What this trial is testing

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 88
Not applicableStudy completedNCT04583891
What this trial is testing

Mobile Apps to Reduce Distress in Breast Cancer Survivors Using an Adaptive Design

Who this might be right for
Depression, AnxietyEngagement, Patient
University of Virginia 313
Not applicableLooking for participantsNCT07135960
What this trial is testing

Breast Cancer BRAs Study (Breast Cancer Biomechanics of Radiotherapy And Surgery)

Who this might be right for
Breast Cancer Patients
Portsmouth Hospitals NHS Trust 45
Early research (Phase 1)Ended earlyNCT00972023
What this trial is testing

DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Barbara Ann Karmanos Cancer Institute 1
Testing effectiveness (Phase 2)Looking for participantsNCT06176261
What this trial is testing

DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs

Who this might be right for
Breast CancerBreast Cancer FemaleMetastatic Triple-Negative Breast Carcinoma+4 more
Nancy Lin, MD 58
Testing effectiveness (Phase 2)Looking for participantsNCT07459673
What this trial is testing

HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission

Who this might be right for
Breast CancerHER2-positive Breast CancerBreast Cancer Stage IV
Memorial Sloan Kettering Cancer Center 60
Not applicableActive Not RecruitingNCT05196269
What this trial is testing

Comparing Decision on Aesthetics After Breast Cancer Locoregional Treatment.

Who this might be right for
Breast Cancer
Fundacao Champalimaud 1,030
Next Page